SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008946
Filing Date
2022-05-10
Accepted
2022-05-10 16:02:48
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idya-20220331.htm   iXBRL 10-Q 2883133
2 EX-10.1 idya-ex10_1.htm EX-10.1 394934
3 EX-10.2 idya-ex10_2.htm EX-10.2 395672
4 EX-10.3 idya-ex10_3.htm EX-10.3 22375
5 EX-31.1 idya-ex31_1.htm EX-31.1 19066
6 EX-31.2 idya-ex31_2.htm EX-31.2 18667
7 EX-32.1 idya-ex32_1.htm EX-32.1 15952
  Complete submission text file 0000950170-22-008946.txt   9348703

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT idya-20220331_cal.xml EX-101.CAL 38755
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idya-20220331_pre.xml EX-101.PRE 297715
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idya-20220331.xsd EX-101.SCH 48472
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idya-20220331_def.xml EX-101.DEF 170359
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idya-20220331_lab.xml EX-101.LAB 417130
58 EXTRACTED XBRL INSTANCE DOCUMENT idya-20220331_htm.xml XML 1386403
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 22909451
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences